A Study in Healthy Adult Male Participants to Learn the Way Vericiguat is Absorbed With and Without Food When Taken as a Single Dose in Liquid Form Suitable for Children Compared to a 10 Milligram (mg) Tablet That Releases the Active Substance Immediately

Exclusion Criteria

• •Incompletely cured pre-existing diseases for which it can be assumed that the absorption, distribution, metabolism, elimination and effects of the study drugs will not be normal
• •Febrile illness (temperature ≥38.0 oC) within 4 weeks prior to admission to the ward
• •A history of relevant diseases of vital organs, of the central nervous system or other organs
• •A history of relevant smell and / or taste disorders
• •Relevant diseases within the last 4 weeks prior to the first study intervention administration
• •Known gastro-intestinal disorders (e.g. stomach ulcers, duodenal ulcers, gastro-intestinal bleeding) or inflammatory bowel disease (e.g. Crohn's disease, ulcerative colitis)
• •Regular use of medicines in the 4 weeks prior to first dosing
• •Regular use of therapeutic or recreational drugs (e.g. carnitine products, anabolics, high-dose vitamins)
• •Use of medication (prescription or over the counter) or herbal products within 2 weeks before first study intervention administration which could oppose the study objectives or which might influence them
• •Criteria which in the opinion of the investigator preclude participation for scientific reasons, for reasons of compliance, or for reasons of the participant's safety